• Oxford Instruments published its 2026 annual report, flagging a stronger second half despite disruption early in the year.
• NanoScience sale completed in January, sharpening focus on Imaging & Analysis and Advanced Technologies.
• Advanced Technologies logged record orders, lifting revenue visibility into FY27 and FY28 as compound semiconductor demand accelerated.
• Imaging & Analysis returned to growth late in the year, helped by restructuring at the Belfast imaging site.
• Capital allocation stayed shareholder-friendly, supported by £42 million net proceeds from the divestment and an ongoing share buyback.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oxford Instruments plc published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein.